State-owned lab has special niche in vaccine research

Article Abstract:

Massachusetts Biologic Laboratories are the only publicly owned, federally licensed manufacturer of vaccines and other biologic products in US to continue with the vaccine manufacturing business. It has reported advance toward developing a SARS vaccine and has helped Massachusetts by supplying tetanus vaccines in the times of shortages.

Drugs, Drug therapy, Severe acute respiratory syndrome

---

Pricey vaccines for kids still public health bargains

Article Abstract:

The cost of children vaccines have risen from $10 per child in 1975 to $385 in 2001, and it is expected to triple over the next two decades as reported in 2004. The various factors responsible for this price-rise are highlighted.

Medical care, Cost of, Health care costs

---

More vaccines, higher cost

Article Abstract:

Future supply and costs of vaccines in the US are discussed.

Vaccines industry

Similar abstracts:

• Abstracts: Changes create new nursing careers. Praise for mental health review. Can counselling take place in acute clinical mental health?
• Abstracts: Groups collaborate on hospital performance initiative. Physicians, public at odds over errors. Study outlines deficiencies in American health care
• Abstracts: Scientists eye new developments on the vaccine front. Balancing research with national security. Review confirms knowledge gap in women's heart research
• Abstracts: Nucleated red blood cells in polycythemic infants. Nucleated red blood cells in infants of mothers with asthma
• Abstracts: Aetna breaks cycle of losses to post profits. Evidence still out on disease management as cost saver. Insurers post robust profits for the second quarter

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.